- First at-home, virtually guided service to bring rapid, reliable and affordable testing into the home where the result is delivered in minutes
- Abbott and eMedâ„¢ expect to deliver and administer 30 million BinaxNOWâ„¢ tests in the first quarter of 2021, with an additional 90 million in the second quarter
- $25 cost for the test and service is the lowest available for at-home testing, which supports the home user to ensure a successful testing process
- BinaxNOW is a highly portable, easy-to-use, 15-minute antigen test with no instrument that detects the virus when people are most infectious, which is critically important in slowing the spread of the virus
- Service uses Abbott's complementary NAVICAâ„¢ app to enable the testing process and display authenticated BinaxNOW test results verified by a trained guide - and supports consumer confidence in testing at home
PR Newswire
ABBOTT PARK, Ill.,, Dec. 16, 2020
